Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration

Abstract Introduction Neovascular age-related macular degeneration is a global public-health concern, associated with a considerable burden to individuals, healthcare systems, and society. The objective of this study was to understand different perspectives on the challenges associated with the clin...

Full description

Saved in:
Bibliographic Details
Main Authors: Anat Loewenstein, Michelle Sylvanowicz, Winfried M. Amoaku, Tariq Aslam, Chui Ming Gemmy Cheung, Bora Eldem, Robert P. Finger, Richard P. Gale, Laurent Kodjikian, Adrian Koh, Jean-François Korobelnik, Xiaofeng Lin, Paul Mitchell, Moira Murphy, Mali Okada, Ian Pearce, Francisco J. Rodriguez, Jude Stern, S. James Talks, David T. Wong, Tien Yin Wong, Focke Ziemssen, Jane Barratt
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-12-01
Series:Ophthalmology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40123-024-01061-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544920940150784
author Anat Loewenstein
Michelle Sylvanowicz
Winfried M. Amoaku
Tariq Aslam
Chui Ming Gemmy Cheung
Bora Eldem
Robert P. Finger
Richard P. Gale
Laurent Kodjikian
Adrian Koh
Jean-François Korobelnik
Xiaofeng Lin
Paul Mitchell
Moira Murphy
Mali Okada
Ian Pearce
Francisco J. Rodriguez
Jude Stern
S. James Talks
David T. Wong
Tien Yin Wong
Focke Ziemssen
Jane Barratt
author_facet Anat Loewenstein
Michelle Sylvanowicz
Winfried M. Amoaku
Tariq Aslam
Chui Ming Gemmy Cheung
Bora Eldem
Robert P. Finger
Richard P. Gale
Laurent Kodjikian
Adrian Koh
Jean-François Korobelnik
Xiaofeng Lin
Paul Mitchell
Moira Murphy
Mali Okada
Ian Pearce
Francisco J. Rodriguez
Jude Stern
S. James Talks
David T. Wong
Tien Yin Wong
Focke Ziemssen
Jane Barratt
author_sort Anat Loewenstein
collection DOAJ
description Abstract Introduction Neovascular age-related macular degeneration is a global public-health concern, associated with a considerable burden to individuals, healthcare systems, and society. The objective of this study was to understand different perspectives on the challenges associated with the clinical management of neovascular age-related macular degeneration, which could elucidate measures to comprehensively improve clinical care and outcomes. Methods A survey was carried out of patients with neovascular age-related macular degeneration, their providers, and clinic staff in 77 clinics across 24 countries on six continents, from a diverse range of healthcare systems, settings, and reimbursement models. Surveys comprised a series of single/multiple-response questions completed anonymously. Data gathered included patient personal characteristics, appointment attendance challenges, treatment experiences, and opportunities to improve support. Provider and clinic staff surveys asked similar questions about their perspectives; clinic characteristics were also captured. Results There were 6425 responses; 4558 patients with neovascular age-related macular degeneration, 659 providers, and 1208 clinic staff. Challenges identified included concern about patient burden to family/friends, high frequency of treatment, difficulties in traveling to appointments, long waiting times, and insufficient comprehension of neovascular age-related macular degeneration. Participants identified logistical (improved financial assistance with treatment and out-of-pocket costs, and appointment reminders), operational (addressing clinic set up to reduce waiting times and improving the amount of time providers spend with patients), and educational (improving quality and provision of patient information and expectation-setting) opportunities to improve care. Conclusions The wealth of data generated by this global survey highlights the breadth of challenges associated with clinical management of patients with neovascular age-related macular degeneration. Addressing the opportunities raised could improve patient adherence to treatment and potentially outcomes, reduce appointment burden, and increase clinic capacity.
format Article
id doaj-art-21c6b95a1b7944e986dd7a4a1f8ebcf6
institution Kabale University
issn 2193-8245
2193-6528
language English
publishDate 2024-12-01
publisher Adis, Springer Healthcare
record_format Article
series Ophthalmology and Therapy
spelling doaj-art-21c6b95a1b7944e986dd7a4a1f8ebcf62025-01-12T12:10:45ZengAdis, Springer HealthcareOphthalmology and Therapy2193-82452193-65282024-12-0114121122810.1007/s40123-024-01061-3Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular DegenerationAnat Loewenstein0Michelle Sylvanowicz1Winfried M. Amoaku2Tariq Aslam3Chui Ming Gemmy Cheung4Bora Eldem5Robert P. Finger6Richard P. Gale7Laurent Kodjikian8Adrian Koh9Jean-François Korobelnik10Xiaofeng Lin11Paul Mitchell12Moira Murphy13Mali Okada14Ian Pearce15Francisco J. Rodriguez16Jude Stern17S. James Talks18David T. Wong19Tien Yin Wong20Focke Ziemssen21Jane Barratt22Department of Ophthalmology, Tel Aviv Medical Center, Faculty of Medicine, Tel Aviv UniversityBayer Consumer Care AGUniversity of Nottingham and Queen’s Medical CentreManchester Royal Eye Hospital, NHS Central Manchester University Hospitals and University of ManchesterDuke-NUS Medical School, National University of SingaporeDepartment of Ophthalmology, Hacettepe UniversityDepartment of Ophthalmology, University Medical Centre Mannheim, University of HeidelbergYork and Scarborough Teaching Hospital NHS Foundation TrustCroix-Rousse University Hospital, University of LyonEye and Retina Surgeons, Camden Medical CentreService d’Ophtalmologie, CHU BordeauxZhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen UniversityUniversity of Sydney (Westmead Institute for Medical Research)Exploristics LtdRoyal Victorian Eye and Ear HospitalRoyal Liverpool University HospitalFundación Oftalmologia Nacional, Escuela de Medicina y Ciencias de la Salud, Universidad del RosarioThe International Agency for the Prevention of BlindnessThe Newcastle Upon Tyne Hospitals NHS FoundationDepartment of Ophthalmology and Vision Sciences, University of Toronto, Unity Health Toronto, St. Michael’s HospitalSingapore Eye Research Institute (SERI)Department of Ophthalmology, University Hospital LeipzigInternational Federation on AgeingAbstract Introduction Neovascular age-related macular degeneration is a global public-health concern, associated with a considerable burden to individuals, healthcare systems, and society. The objective of this study was to understand different perspectives on the challenges associated with the clinical management of neovascular age-related macular degeneration, which could elucidate measures to comprehensively improve clinical care and outcomes. Methods A survey was carried out of patients with neovascular age-related macular degeneration, their providers, and clinic staff in 77 clinics across 24 countries on six continents, from a diverse range of healthcare systems, settings, and reimbursement models. Surveys comprised a series of single/multiple-response questions completed anonymously. Data gathered included patient personal characteristics, appointment attendance challenges, treatment experiences, and opportunities to improve support. Provider and clinic staff surveys asked similar questions about their perspectives; clinic characteristics were also captured. Results There were 6425 responses; 4558 patients with neovascular age-related macular degeneration, 659 providers, and 1208 clinic staff. Challenges identified included concern about patient burden to family/friends, high frequency of treatment, difficulties in traveling to appointments, long waiting times, and insufficient comprehension of neovascular age-related macular degeneration. Participants identified logistical (improved financial assistance with treatment and out-of-pocket costs, and appointment reminders), operational (addressing clinic set up to reduce waiting times and improving the amount of time providers spend with patients), and educational (improving quality and provision of patient information and expectation-setting) opportunities to improve care. Conclusions The wealth of data generated by this global survey highlights the breadth of challenges associated with clinical management of patients with neovascular age-related macular degeneration. Addressing the opportunities raised could improve patient adherence to treatment and potentially outcomes, reduce appointment burden, and increase clinic capacity.https://doi.org/10.1007/s40123-024-01061-3nAMDNeovascular age-related macular degenerationPatient experience
spellingShingle Anat Loewenstein
Michelle Sylvanowicz
Winfried M. Amoaku
Tariq Aslam
Chui Ming Gemmy Cheung
Bora Eldem
Robert P. Finger
Richard P. Gale
Laurent Kodjikian
Adrian Koh
Jean-François Korobelnik
Xiaofeng Lin
Paul Mitchell
Moira Murphy
Mali Okada
Ian Pearce
Francisco J. Rodriguez
Jude Stern
S. James Talks
David T. Wong
Tien Yin Wong
Focke Ziemssen
Jane Barratt
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
Ophthalmology and Therapy
nAMD
Neovascular age-related macular degeneration
Patient experience
title Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
title_full Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
title_fullStr Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
title_full_unstemmed Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
title_short Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
title_sort global insights from patients providers and staff on challenges and solutions in managing neovascular age related macular degeneration
topic nAMD
Neovascular age-related macular degeneration
Patient experience
url https://doi.org/10.1007/s40123-024-01061-3
work_keys_str_mv AT anatloewenstein globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT michellesylvanowicz globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT winfriedmamoaku globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT tariqaslam globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT chuiminggemmycheung globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT boraeldem globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT robertpfinger globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT richardpgale globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT laurentkodjikian globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT adriankoh globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT jeanfrancoiskorobelnik globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT xiaofenglin globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT paulmitchell globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT moiramurphy globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT maliokada globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT ianpearce globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT franciscojrodriguez globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT judestern globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT sjamestalks globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT davidtwong globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT tienyinwong globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT fockeziemssen globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration
AT janebarratt globalinsightsfrompatientsprovidersandstaffonchallengesandsolutionsinmanagingneovascularagerelatedmaculardegeneration